This inventor holds 2 USPTO granted patents. Top assignees: Douglas Pharmaceuticals Limited, Lincoln University, Canterprise Limited. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 19 
2 out of 8 
1 out of 4 
Years Active: 2014-2016
Title: Unveiling the Innovative Mind of Matthew Alan Jones
Introduction:
Matthew Alan Jones, a brilliant inventor based in Christchurch, New Zealand, has left a significant mark in the field of science with his groundbreaking inventions and patents.
Latest Patents:
Jones' latest patents include the revolutionary "Macrocyclic cysteine protease inhibitors and compositions thereof." This novel class of compounds acts as cysteine protease inhibitors, offering new possibilities in the treatment and prevention of diseases associated with calpain activity.
Career Highlights:
Throughout his career, Jones has demonstrated a remarkable talent for innovation. His work at Lincoln University and Douglas Pharmaceuticals Limited has been instrumental in pushing the boundaries of scientific research and pharmaceutical development.
Collaborations:
Collaborating with esteemed colleagues such as Andrew David Abell and James Morriss Coxon, Jones has fostered a culture of innovation and excellence in his workplace. Together, they have contributed to pioneering discoveries that have the potential to impact countless lives.
Conclusion:
In conclusion, Matthew Alan Jones stands as a beacon of innovation, with his relentless pursuit of scientific advancement and problem-solving. His contributions to the field of cysteine protease inhibitors are sure to pave the way for exciting new developments in the realm of healthcare and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile